| Long name: |
ACBD3/GOCAP1 Primary Polyclonal Antibody |
| Also known as: |
ACBD3/GOCAP1 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
ACBD3/GOCAP1 |
| Specificity: |
This is a highly specific antibody against ACBD3/GOCAP1 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ACBD3/GOCAP1 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
ACBD3 is responsible for maintaining Golgi structure and, ACBD3 is thought to act as a peripheral-type benzodiazepine receptor-associated protein, Additionally, Changes in the subcellular location of ACBD3 trigger signaling cascades within the Golgi that regulate cell fate and cell cycle progression, Expressed ubiquitously with highest expression in ovary and testis, GOCAP1, PAP7 or GOLPH1, also known as GCP60 (Golgi resident protein GCP60), functions to mediate protein transport between the Golgi and the endoplasmic reticulum (ER), is a Golgi apparatus membrane protein that contains one ACB (acyl-CoA-binding) domain and one GOLD (Golgi dynamics) domain which is essential for its interaction with other proteins, possibly playing a role in hormonal regulation and steroid formation, through binding to Giantin (golgin subfamily B member 1), ACBD3 (acyl-CoA-binding domain-containing protein 3) |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
ACBD3, Acyl CoA binding domain containing protein 3, Acyl Coenzyme A binding domain containing 3, Acyl-CoA-binding domain-containing protein 3, GCP 60, GCP60, GCP60_HUMAN, GOCAP 1, GOCAP1, GOLPH 1, GOLPH1, Golgi complex associated protein 1, Golgi complex associated protein 1 60kDa, Golgi complex-associated protein 1, Golgi phosphoprotein 1, Golgi resident protein GCP60, PAP 7, PAP7, PBR and PKA associated protein 7, PBR associated protein, PBR- and PKA-associated protein 7, PKA RIalpha associated protein, Peripheral benzodiazepine receptor associated protein PAP7, Peripheral benzodiazepine receptor-associated protein PAP7, Peripherial benzodiazepine receptor associated protein, ACBD 3 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
ACBD3/GOCAP1 |
| Short name: |
ACBD3/GOCAP1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
ACBD3/GOCAP1 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
15453 |
| Gene: |
ACBD3 |
More about : ACBD3 |
| Long gene name: |
acyl-CoA binding domain containing 3 |
| Synonyms gene: |
GOLPH1 GOCAP1 |
| Synonyms gene name: |
60kDa acyl-Coenzyme A binding domain containing 3 , golgi complex associated protein 1 |
| Synonyms: |
GCP60 PAP7 |
| Synonyms name: |
PBR- and PKA-associated protein 7 |
| Locus: |
1q42, 12 |
| Discovery year: |
2001-04-27 |
| GenBank acession: |
AB043587 |
| Entrez gene record: |
64746 |
| Pubmed identfication: |
12692076 20150326 |
| RefSeq identity: |
NM_022735 |
| Classification: |
A-kinase anchoring proteins |
| Havana BLAST/BLAT: |
OTTHUMG00000037560 |